Adicet Bio
ACET
#9448
Rank
A$0.12 B
Marketcap
A$0.80
Share price
-3.75%
Change (1 day)
-47.60%
Change (1 year)

Revenue for Adicet Bio (ACET)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adicet Bio from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A-100%
2022 A$36.72 M173.62%
2021 A$13.42 M-42.36%
2020 A$23.28 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Quaker Houghton
KWR
A$2.80 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$96.70 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$94.52 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$25.25 BN/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
A$84.86 BN/A๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Hawkins
HWKN
A$1.57 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA